- Home
- ACRV vs NXDT Comparison
ACRV vs NXDT Comparison
Compare ACRV & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- NXDT
- Stock Information
- Founded
- ACRV 2018
- NXDT 2012
- Country
- ACRV United States
- NXDT United States
- Employees
- ACRV N/A
- NXDT N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- NXDT Investment Managers
- Sector
- ACRV Health Care
- NXDT Finance
- Exchange
- ACRV Nasdaq
- NXDT Nasdaq
- Market Cap
- ACRV 203.9M
- NXDT 238.6M
- IPO Year
- ACRV 2022
- NXDT N/A
- Fundamental
- Price
- ACRV $6.60
- NXDT $7.00
- Analyst Decision
- ACRV Strong Buy
- NXDT
- Analyst Count
- ACRV 5
- NXDT 0
- Target Price
- ACRV $22.40
- NXDT N/A
- AVG Volume (30 Days)
- ACRV 63.5K
- NXDT 133.6K
- Earning Date
- ACRV 11-13-2024
- NXDT 01-01-0001
- Dividend Yield
- ACRV N/A
- NXDT 9.66%
- EPS Growth
- ACRV N/A
- NXDT N/A
- EPS
- ACRV N/A
- NXDT 0.99
- Revenue
- ACRV N/A
- NXDT N/A
- Revenue This Year
- ACRV N/A
- NXDT N/A
- Revenue Next Year
- ACRV N/A
- NXDT N/A
- P/E Ratio
- ACRV N/A
- NXDT $6.41
- Revenue Growth
- ACRV N/A
- NXDT N/A
- 52 Week Low
- ACRV $3.19
- NXDT $5.89
- 52 Week High
- ACRV $11.90
- NXDT $13.07
- Technical
- Relative Strength Index (RSI)
- ACRV 42.20
- NXDT 69.16
- Support Level
- ACRV $6.56
- NXDT $5.28
- Resistance Level
- ACRV $7.45
- NXDT $7.34
- Average True Range (ATR)
- ACRV 0.47
- NXDT 0.34
- MACD
- ACRV -0.00
- NXDT 0.18
- Stochastic Oscillator
- ACRV 28.12
- NXDT 85.92
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. Revenue sources include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates primarily through its operating partnership and wholly owned subsidiaries.